2014 Q1: GSK Post N892millionPre-tax Profits Continuing In Its Modest Growth By Nairametrics - April 30, 2014 0 Facebook Twitter Pinterest WhatsApp Telegram Leading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise. LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. This site uses Akismet to reduce spam. Learn how your comment data is processed. Popular Implications of the new CBN stance on treasury bill sale to individuals Uche Ndimele - November 12, 2019 8 CBN has directed banks and other financial institutions to stop selling treasury bills to individuals and small firms with effect from November 29th. Analysis: Zenith Bank, cheap and cheerful Blurb Team @Nairametrics - November 13, 2019 2 At N17.15 the stock is off its one-year low of N16 and still at one of its lowest share prices since 2017. Fidelity Bank customers went on Twitter rampage to demand better service Emmanuel Abara Benson - November 13, 2019 0 Many customers of Fidelity Bank Plc (@fidelitybankplc) dragged the bank to Twitter on Monday because of a whole lot of issues.